Single Sign-On Technology: Easing Study Site Burden Now
In the intricate and rapidly evolving landscape of clinical trials, integrating efficient and cutting-edge technology solutions has become a...
Moe Alsumidaie
Stanford’s New Leap in Personalized Medicine and Trials
The forefront of personalized medicine is dramatically reshaped by advancements in biomarker discovery and digital health technologies (DHTs) –...
Digital Health Technologies: New Era in Clinical Research
Digital health technologies (DHTs) are revolutionizing the landscape of clinical research, pushing us toward more innovative and patient-centered trial...
Remarkable Edge in Cancer Vaccine Treatment: New Hope
In this interview, we engage with Andrew Allen, a pioneering force in the field of immunotherapy and the co-founder...
Unique Thyroid Cancer Tests: New Hope Unveiled
In the rapidly evolving landscape of medical research, particularly in the realm of cancer treatment, the development and application...
Your New Guide to Validate Clinical Trial DHTs
The advent of sensor-based Digital Health Technologies (sDHTs) is transforming the landscape of clinical research and patient care. I...
New Tips to Incorporate DCT Elements in Your Clinical Trials
In a pivotal webcast hosted by Medable, a panel of distinguished experts, including Pamela Tenaerts (Chief Scientific Officer at...
The Enhanced eConsent Evolution: A New Era for Trials
A groundbreaking proof-of-concept study conducted by Medable and the Duke BASE Lab unveiled electronic informed consent (eConsent) solutions in...
2024 SCOPE Summit Insights: Navigating New Clinical Trial Change
The 2024 SCOPE Summit catalyzed thought-provoking dialogue on the transformative currents sweeping through the clinical trials landscape. Hassan Kadhim,...
eCOA: Should Sponsors Give Clinical Sites More Control?
Electronic Clinical Outcome Assessments (eCOA) have significantly advanced clinical trials, offering a more accurate and efficient data collection method....